<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>DARU Journal of Pharmaceutical Sciences</JournalTitle><Volume>14</Volume><Issue>2</Issue></Journal><ArticleTitle>Formulation of an injectable implant for peptide delivery and mechanistic study of the effect of polymer molecular weight on its release behavior</ArticleTitle><FirstPage>65</FirstPage><LastPage>70</LastPage><AuthorList><Author><FirstName></FirstName><LastName>Reyhaneh Astaneh</LastName></Author><Author><FirstName></FirstName><LastName>Hamid Reza Moghimi</LastName></Author><Author><FirstName></FirstName><LastName>Mohammad Erfan</LastName></Author><Author><FirstName></FirstName><LastName>Hamid Mobedi</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>06</Day></PubDate></History><Abstract>The effects of polymer molecular weight on drug release from erodible matrices are not well known. It would be more complicated for in-situ forming injectable implants that change gradually from liquid to solid after injection. To investigate this phenomenon, two commerciallyaavailable PLGA polymers (lactic acid-co-glycolic acid) with molecular weights of 12000 and 48000 Da were used to prepare injectable implants containing leuprolide acetate as a model peptide. The influence of polymer molecular weight on the morphology and erosion of matrices and also on their in-vitro drug release behavior over a period of 28 days was investigated. Results showed that the amount of drug released (32%) over the first 24 hours (burst phase) for 12 kDa PLGA system, was significantly (P</Abstract><web_url>https://daru.tums.ac.ir/index.php/daru/article/view/266</web_url><pdf_url>https://daru.tums.ac.ir/index.php/daru/article/download/266/266</pdf_url></Article></Articles>
